Search results
Results from the WOW.Com Content Network
The Beers Criteria for Potentially Inappropriate Medication Use in Older Adults, commonly called the Beers List, [1] are guidelines published by the American Geriatrics Society (AGS) for healthcare professionals to help improve the safety of prescribing medications for adults 65 years and older in all except palliative settings.
Every medication has potential adverse side-effects. With every drug added, there is an additive risk of side-effects. Also, some medications have interactions with other substances, including foods, other medications, and herbal supplements. [46] 15% of older adults are potentially at risk for a major drug-drug interaction. [47]
Medication related harm (MRH) is common after hospital discharge in older adults, but methodological inconsistencies between studies and a paucity of data on risk factors limits clear understanding of the epidemiology. There was a wide range in incidence, from 0.4% to 51.2% of participants, and 35% to 59% of harm was preventable.
More than one in four adults (28%) 65 and older report falling each year, costing the US health system about $50 billion annually. Falls can lead to serious injury, loss of independence, or even ...
An early Alzheimer’s diagnosis is life-changing, whether it happens to you or someone you live with, such as a spouse or an elderly parent. Take these seven steps to make your home comfortable ...
Fall prevention includes any action taken to help reduce the number of accidental falls suffered by susceptible individuals, such as the elderly and people with neurological (Parkinson's, Multiple sclerosis, stroke survivors, Guillain-Barre, traumatic brain injury, incomplete spinal cord injury) or orthopedic (lower limb or spinal column fractures or arthritis, post-surgery, joint replacement ...
The first study analysed cognition and dementia data from the Health and Retirement Study, a nationally representative survey of approximately 20,000 older U.S. adults and their households ...
Withdrawn at request of NDA originator, "not for reason of safety or efficacy." [8] [9] Astemizole (Hismanal) 1999 US, Malaysia, Multiple Nonspecified Markets Fatal arrhythmia [2] [3] Azaribine: 1976 US Thromboembolism. [3] Bendazac: 1993 Spain Hepatotoxicity. [3] Benoxaprofen (Oraflex, Opren) 1982 Germany, Spain, UK, US